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INTERNET DRUG SALES: IS IT TIME TO
WELCOME "BIG BROTHER" INTO YOUR
MEDICINE CABINET?
Ludmila Bussiki Silva Clifton*
Prescription drug sales over the Internet continue to grow as the
Internet becomes an essential means to communicate and conduct
business. The mammoth 150 billion dollar prescription drug industry
increasingly lures entrepreneurs to go online and seize a share of
industry profits.' A 2000 survey indicates that of the ninety-seven
million people using the Internet, seventy-four percent access health
care information on a regular basis. 2 Among these Internet users are
an increasing number of people making purchases from Canadian
online pharmacies. As usage of the Internet for e-commerce
increases, traditional brick and mortar drugstores follow consumers by
opening new storefronts online.4
Internet pharmacies have become popular because of the attractive
combination of lower prices, convenience, and greater privacy.' The
aging population of baby boomers, who have greater familiarity with
computer usage, will most likely lead to a rise in usage of online
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1. Joanna M. Carlini, Liability on the Internet: Prescription drugs and the
virtual pharmacy, 22 WHITTIER L. REV. 157, 157 (2000).
2. Online Health: Number of Users Continues to Grow, AMERICAN HEALTH
LINE (The Nat'l Journal Group Inc.), Aug. 5, 1999.
3. Mary Pat Flaherty & Gilbert Gaul, Millions of Americans Look Outside
U.S. for Drugs, WASH. POST, Oct. 23, 2003, at Al.
4. Carlini, supra note 1, at 157.
5. UNITED STATES GENERAL ACCOUNTING OFFICE, GAO-01-69, INTERNET
PHARMACIES: ADDING DISCLOSURE REQUIREMENTS WOULD AID STATE AND
FEDERAL OVERSIGHT (2000).
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pharmacies. Segments of the population, such as the elderly, residents
of rural areas, and those homebound because of illness or disability
benefit greatly by using the Internet to purchase needed medications.6
These citizens are in trouble because Internet prescription sales have
become a double-edged sword. On the one side, they offer potential
cost savings to consumers, and on the other, they rely on an inefficient
patchwork of state and federal regulations that are unable to offer
uniform and adequate consumer protection. As a result of this lack of
uniform regulation, many unscrupulous and sometimes illegitimate
online pharmacies threaten the innocent consumer's life and well-
being.7
Currently, states have the responsibility for establishing and
enforcing the procedures necessary for operating an online drugstore
such as licensing and regulating out-of-state pharmacies that want to
ship medications to residents of the state. As a result, consumer
protection is largely dependent upon state regulations. Unfortunately,
the states' regulatory mechanism is marked by discrepancies, because
some states take a more proactive role, while other states leave the
field totally unregulated.8 States' budgets vary widely. Thus, some
poorer states simply do not have the resources to provide meaningful
oversight of Internet drug sales. At the federal level, several
administrative agencies, such as the Food and Drug Administration
(FDA), the Drug Enforcement Agency (DEA), and the Department
of Justice (DOJ), provide limited and often times overlapping
regulations of online pharmacies. State and federal governments
currently have an inefficient regulatory regime leaving many
loopholes.
Because of this current inefficiency, Congress must enact legislation
to enable the federal agencies to implement the necessary regulations
to safeguard consumers. Part I of this comment provides background
information into the reasons for the popularity in buying prescriptions
online. Part II provides an overview of the types of online pharmacies
6. Kristin Yoo, Self-Prescribing Medication: Regulating Prescription Drug
Sales on the Internet, 20 J. MARSHALL J. COMPUTER & INFO. L. 57, 61 (2001).
7. Carlini, supra note 1, at 159.
8. In order to establish a nonresident pharmacy to ship, mail, or deliver drugs
in Mississippi, all that is needed is to register with the state. The State Board of
Pharmacy relies on the disclosure by the applicant and does not require the
substantiation of any records. See Application for Non-Resident Pharmacy Permit
2004-2005, Mississippi State Board of Pharmacy [hereinafter Mississippi State
Board of Pharmacy], available at http://www.mbp.state.ms.us/nrretailapp.pdf (last
visited May 13, 2004).
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and how they operate in the current legislative vacuum. Part III
discusses the various states' attempts at regulating online pharmacies. 9
Part IV outlines the existing federal regulatory patchwork among the
various agencies. Finally, Part V argues that the only feasible solution
is to have the federal government create a uniform body of law dealing
specifically with online drug sales, thereby targeting the problems that
are unique to online drug prescribing and online drug dispensing.
I. REASONS FOR THE POPULARITY OF INTERNET PHARMACIES
A. Demand: Americans Go Online for Convenience, Privacy, and Price
Historically, the United States has had one of the safest systems in
the world to deliver prescription drugs to the consumer, because the
Food and Drug Administration (FDA) has been able to effectively
regulate the domestic sale of prescription drugs.'0 Prior to the advent
of Internet pharmacies, the sale of prescription drugs were done
pursuant to a rigid screening process. Drugs could only be purchased
from brick and mortar pharmacies or by well-known mail order
outlets. This limitation did not represent a pocketbook issue to
consumers because prescription drug prices did not impose as much of
a financial burden on consumers as they do today. Likewise,
importation of drugs from overseas was not as readily available as
today. Since the advent of online pharmacies, there has been an
increase in illegal sales of prescription drugs, unsafe foreign
pharmacies, and fraudulent online pharmacies. 1
Some online pharmacies are a mere extension of the "mail order
pharmacy," which only fills current prescriptions written by a doctor
who has seen the patient.12 This model is not the danger. The current
risks to the health care of citizens reside in the other types of online
pharmacies.
9. Part III offers an overview and is by no means an exhaustive or even
complete list of all state regulations in the field.
10. Food and Drug Administration, The Risks of Buying Medicines From
Across the Border or Around the World, at http:// www.fda.gov/cder/consumerinfo/
borderArticle.pdf (last visited Apr. 10, 2004).
11. Mary Pat Flaherty & Gilbert Gaul, U.S. Prescription Drug System Under
Attack, WASH. POST, Oct. 19, 2003, at Al.
12. Yoo, supra note 6, at 63.
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A riskier type of online pharmacy is designed like a patient-doctor
office visit without any face-to-face consultation.13 Generally, patients
fill out a brief medical questionnaire which is then transmitted to the
drug retailer via the Internet.' 4 At the receiving end is an "online
physician" who reviews the information and ships the drugs directly to
the "patient's" home." Through this arrangement the consumer
realizes greater privacy and convenience." However, the lack of
patient-physician interaction is dangerous in that it does not allow the
physician to examine the patient, nor does it allow the physician to ask
probing questions to determine whether the particular medication
requested is indeed suited for a particular patient. The physician is
also unable to advise the patient of potential side effects or under what
circumstances the patient should seek help from his primary care
doctor.
Although privacy and convenience may factor in to a consumer's
decision to buy prescriptions online, price may be the main
motivation. 17 The emergence of Internet drugstores affects market
conditions of the traditional pharmacy sector by introducing an
additional venue for prescription sales. Internet pharmacies gain a
competitive advantage through lower operating costs than those of
traditional brick and mortar locations. These savings are passed on to
consumers through lower prices , as evidenced in a 2001 study by the
General Accounting Office which found that prescription prices for
certain medications were cheaper online than at traditional
drugstores.' 9
13. Amy J. Oliver, Internet Pharmacies: Regulation of a Growing Industry, 28
J.L. MED. & ETHICS 98, 98 (2000).
14. Id.
15. Id.
16. Carlini, supra note 1, at 158.
17. UNITED STATES GENERAL ACCOUNTING OFFICE, GAO/T-HRD-93-5,
PRESCRIPTION DRUGS: COMPANIES TYPICALLY CHARGE MORE IN THE UNITED
STATES THAN IN CANADA (1993).
18. Internet Tax Non-Discrimination Act of 2003, S. 150, 108th Cong. § 2
(2003).
19. UNITED STATES GENERAL ACCOUNTING OFFICE, GAO-02-280R,
PRESCRIPTION DRUGS: PRICES AVAILABLE THROUGH DISCOUNT CARDS AND
FROM OTHER SOURCES (2001).
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B. Legislative Initiatives
Various members of Congress have introduced legislation in an
effort to keep Internet prescription prices from rising. Internet sales
are temporarily exempted from taxation.20 For example, the North
American Prescription Price Act of 2003, if approved, would make the
temporary tax exemption into a permanent tax moratorium on
Internet purchases.2 If this legislation is passed, the lack of taxation
on prescriptions purchased online will present a source of savings for
consumers. In order to remain competitive, traditional pharmacies will
likely have to cut their prices. Ultimately, this Act will allow
consumers to purchase prescription drugs at lower prices either online
or at traditional pharmacies.
Another legislative effort is Representative John J. Duncan's (R-
TN) proposal to give drug manufacturers an income tax credit.23 This
tax credit will be accessible if the drug manufacturers can certify that
the prices charged in the United States are not greater than the prices
24
charged for the same drugs in Canada or Mexico. The credit will
cause Internet pharmacies to lose some of their price advantage and
thus likely curb some growth in online pharmaceutical sales.
An additional measure introduced in the Senate is the Preserving
Prescription Drug Act.2 This legislation would disallow tax credits and
deductions for companies that discriminate against Canadian
pharmacies that pass their discounts along to U.S. consumers. The
effect would be to force drug manufacturers to lower their prices in the
United States to match the lower prices offered to Canadian
27
consumers.
20. 47 U.S.C. § 151 (2003).
21. S. 150.
22. Id.
23. North American Prescription Price Equity of 2003, H.R. 354, 108th Cong. §
2 (2003).
24. Id.
25. See Preserving Prescription Drug Discounts Act, S. 477, 108th Cong. § 2801
(2003).
26. Id.
27. Id.
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II. AN OVERVIEW OF ONLINE PHARMACIES
A. Types of Online Pharmacies
Online pharmacies are divided into three broad categories:
traditional online pharmacy, prescribing-based site pharmacy, and
rogue pharmacy. 2' The first category, traditional online pharmacy,
operates much the same way as mail order pharmacies.2 9  The
pharmacy uses state-licensed pharmacists and requires consumers to
have a valid prescription sent to them before an order may be filled
online.3° As a safety measure, the pharmacy may on a case-by-case
basis check with the prescribing physician before mailing the requested
order.31
The second category, prescribing-based site, performs a two-step
32
service. The first step is diagnosis. The patient fills out a general
medical questionnaire, including medications the patient may be
currently taking and the patient's medical history. Using this
information, the online doctor offers to diagnose the patient. Once the
doctor gives a diagnosis, the online doctor is then able to prescribe the
medication.
The third category, rogue pharmacy, presents the greatest danger to
consumers.3 This type of online pharmacy allows a customer to
purchase medication without any prescription and without any online
diagnostic service.34 Consumers who try to self-diagnose may be
unaware of the possible side effects of certain medications. Those
consumers also risk an adverse reaction with other prescriptions they
may already be taking.35
28. Carlini, supra note 1, at 159.
29. Yoo, supra note 6, at 63.
30. Flaherty & Gaul, supra note 11.
31. Yoo, supra note 6, at 63.
32. Id.
33. Id. at 64.
34. Id. at 65.
35. Id.
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B. Dispensing and Prescribing
A distinction needs to be made between dispensing and prescribing
medications over the Internet. Internet dispensing involves the
delivery of prescription drugs by an online pharmacy.37 Internet
prescribing arises when the online pharmacy prescribes the drug to the
consumer absent a physical examination.38 While both methods pose
significant health risks, the latter is more dangerous because the
pharmacy plays the role of both doctor and pharmacist. This dual role
can be potentially fatal to the consumer. 9 Prior to the advent of the
Internet, prescription drugs were not available without a face-to-face
encounter between physician and patient.40 A patient's knowledge of a
particular prescription drug was usually limited to the information
provided by his or her doctor. With the advent of the Internet, this is
no longer the case.
There is widespread agreement over the ability of patients to get
information and drugs online; however, there is disagreement between
the Federation of State Medical Boards (FSMB) and the American
Medical Association (AMA) on the desirability of online prescribing
absent a physician-patient relationship. In April 2000, the FSMB
delineated its policy on online prescribing:
Treatment and consultation recommendations made in an online
setting, including issuing a prescription via electronic means, will
be held to the same standards of appropriate practice as those in
traditional (face-to-face) settings. Treatment, including issuing a
prescription, based solely on an online questionnaire or
41consultation does not constitute an acceptable standard of care.
While the FSMB allows some degree of online prescribing, the
AMA takes a stricter view on the matter by requiring a prior
physician-patient relationship in order to provide medical care. The
Association highlights the need for physicians to recognize the
36. Kara M. Friedman, Internet Prescribing Limitations and Alternatives, 10
ANNALS HEALTH L. 139, 143 (2001).
37. Id.
38. Id.
39. Id.
40. Id. at 140.
41. FEDERATION OF STATE MEDICAL BOARDS OF THE UNITED STATES, MODEL
GUIDELINES FOR THE APPROPRIATE USE OF THE INTERNET IN MEDICAL PRACTICE
(2002) [hereinafter FSMB], available at http://www.fsmb.org (last visited May 13,
2004).
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importance of establishing and maintaining a physician-patient
relationship and to be aware of patients' rights and privacy whether or
not there has been physical contact between the physician and the
42patient.
C. The Rise of Online Prescribing: Lowered Managed Care
Expectations and the FDA's Advertising Regulation
In recent years, managed care has lowered expectations of the
doctor-patient relationship because it has caused patients to switch
doctors whenever a doctor is dropped from the managed care
organization's approved provider list.4 3 Patients have lost the closeness
with their physicians that they once had, while the physician's role is
no longer that of a counselor, friend, or support system." Today,
consultations with a physician are too brief for the doctor to get to
know the patient. 45 As a result, the managed care environment has
degraded the doctor-patient relationship and has led to lower
expectations.
In addition to lowered expectations of the doctor-patient
relationship, pharmaceutical companies have increased direct-to-
consumer advertising, thereby in the patient's eyes reducing the need
for a physician to be involved in determining what drug therapy to
use." While the FDA discourages direct advertising of prescription
drugs to consumers, direct advertising is permitted.47 The first FDA
regulations for prescription drug advertising were established in 1963.4
They require drug manufacturers to disclose all adverse information
about the prescription drug, including its side effects and contra-• • • 49
indications. It was not until 1985 that the FDA lifted the moratorium
on "Direct-to-Consumer" advertising, but it continued to discourage
42. Id.
43. Ronald L. Scott, Cybermedicine and Virtual Pharmacies, 103 W. VA. L.
REV. 407, 411 (2001).
44. Id.
45. Id.
46. Andrew Somora, Direct-to-Consumer Advertising: Are Consumers Being
Informed?, 8 KAN. J. L. & PUB. POL'Y 205, 206 (1999).
47. Id.
48. 15 U.S.C. § 55 (a)(1) (1964).
49. Id.
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the practice. 0 In 1999, the FDA relaxed its rules concerning broadcast
advertising and issued final regulations for the industry."1 These
regulations required the industry to disclose fully the risks of each
52prescription drug.
As a result of increased advertising by drug manufacturers via the
web, television, radio, and email subscription lists, patients have gained
new knowledge of the many drugs available to treat their problems,
allowing for self-diagnosis. 3 This is a marked shift in philosophy from
"doctor knows best''4 to patients now asking their doctors for
particular drugs.5 Putting patients in the "driver's seat" does have the
benefit of allowing greater control over one's own health decisions,
which can be crucial at a time when many citizens are uninsured,
underinsured, or lacking prescription drug coverage. 6  However,
allowing direct-to-consumer advertising by drug manufacturers causes
some consumers to undermine the physician's role by self-medicating.
Online pharmacies make this possible by eliminating the need for a
doctor to physically examine a patient prior to prescribing
medication. 7
The FDA's progressive relaxation of prescription advertising to
consumers has created problems for state regulation of online
pharmacies. This has allowed patients to learn about dangerous
prescription drugs while the Internet has become a viable way to
purchase them. States have the primary responsibility for licensing
pharmacies, but faced with the public's ability to acquire dangerous
drugs, the states are unsure how to proceed. State legislatures have
50. Somora, supra note 46, at 205.
51. April L. Foreman, Web of Manipulation: The Learned Intermediary
Doctrine and Direct-to-Consumer Advertising on the World Wide Web, 35 J.
MARSHALL L. REV. 97, 100-101 (2001).
52. Id.
53. Id. at 102; see also Prozac dosage information, at http://www.mentalhealth.
com/drug/p30-p05.html#Head-l (last visited Apr. 7, 2004); Advertisement for
Nexium, "the purple pill," along with dosage information, at http:// www.purple
pill.com (last visited Apr. 7, 2004).
54. See, e.g., Perez v. Wyeth Labs. Inc, 734 A.2d 1245, 1255 (N.J. 1999).
55. Id.
56. Vida Foubister, Getting Prescriptions to the People, available at
http://www.ama-assn.org/sci-pubs/amnews/pick-00/prsal023.htm (last visited Nov.
22, 2003) (noting thirty-one percent of seniors lack prescription drug coverage).
57. For an example of online pharmacy that does not require physical
examination prior to prescribing medication, see Cheap-Online-Pharmacy.org, at
http://www.cheap-online-pharmacy.org (last visited May 13, 2004).
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reacted by framing the question as, How do we stop this? rather than,
How do we regulate this?58 The reality is that the Internet will not
simply disappear. As long as this mode of communication is available,
there will be pharmacists and doctors willing to take the risk and
prescribe medication online. Likewise, there will be individuals
desperate for more affordable drugs who are willing to jeopardize their
own health in an attempt to secure needed medication. Those who are
terminally ill may be the most susceptible to purchasing unapproved
drugs because of their desire to prolong life regardless of the risks. 9
III. STATE REGULATORY FRAMEWORK
A. The implications of the doctor-patient relationship for online
medicine
States have historically regulated health care providers and health
insurance.6 Prescription dispensing is another related area that states
have historically regulated.61  Consequently, states are regulators of
both the professionals who render medical advice as well as the
businesses that sell the medicine. Accordingly, the states play a key
role in protecting consumers from the risks involved in buying
prescription drugs online.
Unfortunately, there are widespread discrepancies between state
laws regarding online drug dispensing and prescribing.62 Some states
have no regime to regulate online drug sales.63 Other states require
patients to have a valid physician-patient relationship and a physical
examination before allowing a doctor to prescribe drugs.64 This lack of
uniformity allows a resident from one state to be diagnosed by an
online physician in a less regulated state. The question over what
constitutes a valid doctor-patient relationship becomes crucial in order
to safeguard consumers.
58. Scott, supra note 43, at 422.
59. Friedman, supra note 36, at 146.
60. FSMB, supra note 41.
61. See, e.g., MD. REGS. CODE tit. 10, § 7, chp. 02, reg. 15 (2003).
62. Sean P. Haney, Pharmaceutical Dispensing in the "Wild West": Advancing
health care and protecting consumers through the regulation of online pharmacies,
42 WM. AND MARY L. REV. 575,603-606 (2000).
63. Mississippi State Board of Pharmacy, supra, note 8.
64. Id.
Internet Drug Sales
An important issue that arises is at what point the doctor-patient
relationship begins.65 The determination of what constitutes a doctor-
patient relationship may be restricted to those instances in which both
parties are physically present. Alternatively, it can be broadened to
incorporate telemedicine, which allows for a physician in another state
to practice medicine across state borders without ever having to be
physically present in that state.66 In such cases there is never a face-to-
face meeting with the physician.67 The FSMB takes the position that
the doctor-patient relationship begins when an individual seeks
assistance from a physician on a health-related matter.68 The FSMB
further elaborates, "[T]he relationship is clearly established when the
physician agrees to undertake diagnosis and treatment of the patient
and the patient agrees to that treatment, whether or not there has been
a personal encounter between the physician (or other supervised
health care practitioner) and patient. 69
Of the states with a prescription regulation regime, Maine, New
Hampshire, and Vermont require that "any medical service to a
patient requires a professional licensor in the state in which the patient
encounter will occur. 70  A physician needs to be licensed and
therefore in compliance with the laws of the state in which the patient
lives. This allows these states to restrict physicians licensed in other
states from rendering medical advice to its residents. In these states a
patient-doctor relationship does not occur unless a doctor is licensed in
that state.
Oklahoma, Maryland, Alabama, Ohio, and Texas have also adopted
guidelines for online drug sales.7' California, Illinois, and Oregon have
been even more proactive by taking steps to hold physicians who
prescribe medication in violation of Internet communication standards
accountable for their actions.7 ' Arizona, California, and Virginia have
enacted measures to create standards for prescribing medications
online.7 ' Delaware, Michigan, and New York have introduced similar
65. Id.
66. FSMB, supra note 41.
67. Scott, supra note 43, at 412-413.
68. FSMB, supra, note 41.
69. Id.
70. Friedman, supra note 36, at 160.
71. Id.
72. Id. at 161.
73. Id.
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legislation.7 4 However, California remains the only state with a full-
time agent dedicated to investigating online pharmacies.75
Following in the footsteps of California, over a dozen other states
have taken some kind of action against Internet pharmacies. For
example, Kansas has prohibited several pharmacies from operating
illegal websites.76 These sites made false promises of a cure by advising
consumers to "cancel surgery, radiation or chemotherapy in favor of
herbal cures that cost hundreds of dollars., 77 In another instance a
website recommended St. John's Wort as an alternative treatment for
HIV/AIDS.8  It is well known in the medical community that St.
John's Wort interferes with HIV medications.79
The National Association Boards of Pharmacy (NABP)8° is a
national organization that represents all of the states' boards of
pharmacy. Since 1904, the NABP has worked alongside states in
developing, implementing, and enforcing uniform standards.8' The
NABP is responsible for the development of the North American
Pharmacist Licensure Examination and other tests that are utilized by
the state boards in order to assess the competence of candidates to
practice pharmacology.
In the spring of 1999, NABP created the Verified Internet Pharmacy
Practice Sites (VIPPS) 83 to address concerns about the potential
dangers associated with online pharmacies. The goal of the program is
to encourage Internet pharmacies to comply with the licensing and
inspection laws of the states in which they are located as well as each
74. Id.
75. Flaherty & Gaul, supra note 11.
76. John Henkel, Buying Drugs Online: It's Convenient and Private, but
Beware of 'Rogue Sites', FDA CONSUMER, Jan.-Feb. 2000 (revised in Jun. 2000 &
Mar. 2001), at http://www.fda.gov/fdac/features/2O0O/1OO_online.html (last visited
May 13, 2004).
77. Press Release, Federal Trade Commission, "Operation Cure.All" Wages
New Battle in Ongoing War Against Internet Health Fraud (Jun. 14, 2001),
available at http: www.ftc.gov/opa/2001/06/cureall.htm (last visited May 13, 2004).
78. Id.
79. Id.
80. See generally National Association Board of Pharmacy website, at
http://www.nabp.net (last visited Sept. 9, 2003). The NABP is made up of the
Boards of Pharmacy from the fifty states, the District of Columbia, three U.S.
territories, nine Canadian Provinces and four Australian states.
81. Id.
82. Id. at http:// www.nabp.net/vipps/intro.asp (last visited Nov. 22, 2003).
83. Id.
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state to which they ship pharmaceutical goods.84 In addition, VIPPS
requires that the pharmacies must provide meaningful consultation
between the patient and the pharmacist. 85 In return for complying with
the requirements, pharmacies can then display the VIPPS logo on their
86website. This is important because it creates an aura of credibility for
the online pharmacy; however, VIPPS has no express requirement that
pharmacies only fill prescriptions for patients who have a valid
physician prescription.87
B. A Major Problem for State Regulation of Online Pharmacies:
Seniors and Foreign Pharmacies
A central reason why states cannot effectively regulate online
pharmacies is that much of the commerce is between citizens of the
state and foreign pharmacies. The U.S. Department of Customs
estimates that approximately ten million U.S. citizens per year enter
the United States with foreign medications. An additional two million
prescription packages arrive by mail from countries in Asia; still more
purchases are made from Canadian online pharmacies. The
Commerce Clause of the Constitution gives Congress the power to
"regulate commerce with foreign Nations." 88 Hence, states do not
have the power to set up rules prohibiting entry of foreign drugs into
the country.
The sale of prescription drugs from foreign pharmacies is
particularly troublesome. Though drugs sold over the Internet may be
legal in the country where the pharmacy is located, they may not have
been approved by the FDA for use in the United States.89 These drugs
have not undergone the rigorous trials the FDA imposes before
authorizing a new drug to be marketed in the United States.9°
According to the AMA, there are between three-hundred and four-
hundred Internet sites selling prescription drugs, approximately half of
84. Id.
85. Id.
86. Id.
87. Id.
88. U.S. Const., art. I, § 8.
89. Markian Hawryluk, Drugs without borders: When prescription drugs go
over the line, AM. MED. NEWS (Oct. 22/29, 2001), at http://www.amaassn.org/amed
news/2001/10/22/gvsa1022.htm.
90. Id.
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which are based outside the United States. 91 The FDA recently
estimated that two million parcels of prescription drugs enter the
92United States for personal use each year. Since the sites are not
required to post their physical addresses, it is difficult for consumers to
be confident in the pharmacy's location and reputation.93 Lack of a
known physical location also makes it difficult for the states to
investigate these pharmacies because of questions regarding
jurisdiction. Even though it is illegal for a foreign pharmacy to ship
drugs into the United States,94 enforcement is difficult because those
overseas pharmacies do not come within the jurisdiction of the United
States.95 For instance, in Mexico there is no federal regulatory body,
such as the FDA, overseeing drug safety.96 This has led the FDA to
warn consumers of the potential risks involved in purchasing a
medication from an unregulated site. One such risk is that the
prescription may be coming from overseas. The FDA has found that
few imported drugs have adequate instruction labels in English.9
Despite the potential harmful effects of purchasing prescriptions
online, many consumers are still attracted to this channel. The main
91. Id.
92. Preserving Access to Safe, Affordable Canadian Medicines Act of 2003,
H.R. 847, 108th Cong. § 2 (2003).
93. UNITED STATES FOOD AND DRUG ADMINISTRATION, BUYING MEDICINE
AND MEDICAL PRODUCrS ONLINE [hereinafter BUYING MEDICINE ONLINE], at
http:/ www.fda.gov/oc/buyonline/default.htm (last visited May 13, 2004).
94. H.R. 847.
95. Yoo, supra note 6, at 57.
96. Id.
97. BUYING MEDICINE ONLINE, supra note 91. On its website, FDA issues the
following warning to consumers who shop for medicines on line:
You may receive a contaminated or counterfeit product, the wrong
product, an incorrect dose, or no product at all. Taking an unsafe or
inappropriate medication puts you at risk for dangerous drug interactions
and other serious health consequences. Getting a prescription drug by
filling out a questionnaire without seeing a doctor poses serious health
risks. A questionnaire does not provide sufficient information for a
health-care professional to determine if that drug is for you or safe to use,
if another treatment is more appropriate, or if you have an underlying
medical condition where using that drug may be harmful.
Id.
98. See Hawryluk, supra note 89.
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motivation is potential cost savings. 99 According to the General
Accounting Office (GAO), a consumer in the United States pays on
average one-third more for the same prescription drug as would a
consumer in Mexico or Canada.'0 In addition, costs for prescription
drugs have risen on average over twelve percent a year between 1993
and 1998, while overall health care expenditures only rose five percent
per year within the same time period.1 1
Senior citizens are the most vulnerable online prescription consumer
population, due in part to the fact that one-third of the seniorS102
population is without prescription drug insurance. These seniors pay
on average fifteen percent more for a prescription than those who have
drug coverage. 03 Seniors who do have coverage typically use twenty-
one prescriptions a year, compared with sixteen for those who do not
have insurance coverage. 4 The average senior citizen has two to
twenty-one chronic conditions.05 A drug for one chronic condition can
cost anywhere from $500 to $3,000 per year&6  In light of this
predicament, many people go to Canada or Mexico to buy prescription
drugs or choose to purchase them online.107 Recently, cities and states
faced with budget considerations have also started filling their
prescription orders from Canadian suppliers in order to afford the
costs of providing government employees with a prescription coverage
benefit.'0 8
99. UNITED STATES GENERAL ACCOUNTING OFFICE, supra note 17; UNITED
STATES GENERAL ACCOUNTING OFFICE, GAO/HRD 92-128, PRESCRIPTION
DRUGS: CHANGES IN PRICES FOR SELECTED DRUGS (1992).
100. Medicare Payment Restoration and Benefits Improvement Act of 2003,
H.R. Res. 26, 108th Cong. (2003).
101. Id.
102. Foubister, supra note 56.
103. H.R. Res. 26.
104. See Foubister, supra note 56.
105. Id.
106. Id.
107. Julie Appleby, Firm fights for Canadian Drugs, USA TODAY, Oct. 7, 2003,
at 3B.
108. See Prescription Drug Price Parity for American Act, S. 2244, 107th Cong.
§2 (2002); see also H.R. 4954, 107th Cong. (2002).
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IV. FEDERAL REGULATORY FRAMEWORK
A. The Current Framework of Federal Regulatory Oversight of Internet
Pharmacies
The federal regulatory framework in the United States for Internet
pharmacies consists of a patchwork of regulations promulgated from
various federal agencies. These agencies include the Food and Drug
Administration (FDA), Federal Trade Commission (FTC),
Department of Justice (DOJ), Federal Bureau of Investigation (FBI),
U.S. Customs, Drug Enforcement Agency (DEA), and the National
White Collar Crime Center.
1. The Food and Drug Administration
The FDA operates under the Department of Health and Human
Services (HHS). The Secretary of HHS delegates authority to the
FDA Commissioner.1°9 The FDA regulates the field of prescription
drugs via the Federal Food, Drug and Cosmetic Act (FDCA). "° The
Act sets forth a detailed body of regulation for drugs. It prohibits the
"introduction or delivery for introduction into interstate commerce of
any food, drug, device or cosmetic that is adulterated or
misbranded.'. 1 . An article is considered misbranded if it is dispensed
without a valid physician's order completed in accordance with the
law.11 2  In addition, the FDCA prohibits the interstate shipment,
including importation, of unapproved new drugs."' The FDA also
109. 21 C.F.R. § 5.10 (2003).
110. Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 (2000).
111. 21 U.S.C. § 331(a) (2000).
112. See Friedman, supra note 36, at 147; 21 U.S.C. 353(b) (2000).
113. See UNITED STATES FOOD AND DRUG ADMINISTRATION, IMPORTATION OF
PRESCRIPTION MEDICINE/DRUGS, at http://www.fda.gov/ora/import/traveleralert.
htm (last visited May 13, 2004).
Unapproved new drugs are any drugs, including foreign-made versions of
U.S. approved drugs, that have not received FDA approval to
demonstrate they meet the federal requirements for safety and
effectiveness. It is the importer's obligation to demonstrate to FDA that
any drugs offered for importation have been approved by FDA.
Id. (citing 21 U.S.C. §§ 331(d)-355(a)) (2000).
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enforces the provisions of the Fair Packaging and Labeling Act,'4
which requires packages to have accurate information. Currently, the
FDA is unable to enforce the laws HHS has delegated to it because it
simply does not have the manpower to inspect every package at the
border or in the mail.' Recognizing its limited resources, in 2001 the
FDA sent a memo to HHS Secretary Tommy Thompson proposing
that "all medication mailed into the United States be returned to its
sender, except for a fraction that doctors could import for gravely ill
patients." 6 The Secretary has yet to respond."7
2. The Federal Trade Commission
The FTC's power to regulate online pharmacies is derived from its
power to regulate interstate commerce via the Federal Trade
Commission Act." 8 The Act prohibits "unfair or deceptive practices in
or affecting commerce."" 9 Specifically the FTC is "responsible for the
administration of a variety of statutes, which in general, are designed
to promote competition and to protect the public from unfair and
deceptive acts and practices in advertising and marketing of goods and
services. 120 Relying on its power to regulate deceptive advertising
practices, the FTC in July 1999 announced a program called
"Operation Cure All" which targets false claims of products and
treatments advertised as cures for certain diseases.21
In its first two years of enforcement, the FTC identified eight-
hundred sites and newsgroups containing questionable practices. 22 As
a result of the FTC's enforcement actions, four companies entered into
a consent decree with the government over the FTC charges of
deceptive health claims.2' These charges included sites that claimed to
"cure arthritis with a fatty acid derived from beef tallow, to treat
114. 15 U.S.C. § 1451 (2000).
115. Flaherty, supra, note 3.
116. Id.
117. Id.
118. 15 U.S.C § 45 (2000).
119. Id.
120. 16 C.F.R. § 0.1 (2004).
121. See generally Federal Trade Commission, at http://www.ftc.gov (last visited
on Nov. 22, 2003).
122. Henkel, supra note 76.
123. Id.
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cancer and AIDS with a Peruvian plant derivative and to treat cancer
and high blood pressure with magnetic devices., 124  The FDA is
participating with the FTC in "Operation Cure All" by issuing "cyber
letters" to advise operators of Internet pharmacy websites that the
products being marketed may not be in compliance with federal law.'5
3. The Department of Justice
The DOJ oversees subordinate agencies, including the DEA and the
FBI. 12  The Computer Crime and Intellectual Property Section
(CCIPS) functions within the DOJ and its purpose is to patrol the
Internet in an effort to uncover illegal .7 In addition, it has
created a division to provide consumers with information regarding
Internet fraud. Consumers may file a formal complaint against an
Internet pharmacy, which will initiate an investigation by the DOJ.
28
4. The Drug Enforcement Agency
Congress' ability to regulate controlled substances flows from its
power to regulate interstate commerce129 due to its finding that
"controlled substances distributed locally usually have been
transported in interstate commerce immediately before distribution. '"
The DEA is responsible for enforcing the Controlled Substances Act
and the Comprehensive Drug Abuse Prevention and Control Act of
1970. 131 Title II of the Comprehensive Drug Abuse Prevention and
Control Act regulates the manufacture and distribution of narcotics
124. Id.
125. Id.
126. 28 C.F.R. § 01 (2004).
127. Friedman, supra note 33, at 152.
128. UNITED STATES DEPARTMENT OF JUSTICE, How TO REPORT A COMPLAINT
ABOUT WASTE, FRAUD, ABUSE, OR MISCONDUCT IN THE DEPARTMENT OF JUSTICE,
at http://www.usdoj.gov/fraud.htm (last visited May 13, 2003).
129. U.S. Const., art. I, § 8.
130. 21 U.S.C. § 801 (2004).
131. Id.
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and chemicals used in the production of controlled substances. 13 2 The
DEA has issued guidance entitled "Dispensing and Purchasing
Controlled Substances Over the Internet" aimed at educating
prescribers and pharmacists about the use of the Internet in the sale of
controlled substances.3 3 More recently, the DEA has targeted specific
prescriptions which have seen an increase in abuse, particularly
medication to treat severe pain, such as OxyContin.34  A recent
Internet search for OxyContin, however, yielded a website selling the
drug and luring consumers with its promise of "no prescription"
135
necessary.
5. The Federal Bureau of Investigation
The FBI also plays a role in the federal enforcement against
136
unscrupulous online pharmacies. The agency has dedicated a special
portion of its website to alert senior citizens to the danger of
purchasing prescription drugs online. 37 The FBI has partnered with
the National White Collar Crime Center (NW3C) to provide for an
Internet Fraud Complaint Center (IFCC). 138 The IFCC's mission is to
address fraud committed specifically over the Internet. For victims of
Internet fraud, the IFCC provides a convenient and easy-to-use
reporting mechanism that alerts authorities to a suspected criminal or
civil violation.1 39 The IFCC's expertise in dealing exclusively with
Internet fraud allows law enforcement and regulatory agencies at all
132. Controlled Substances Act, 21 U.S.C. § 801 (2000); see also UNITED STATES
DRUG ENFORCEMENT ADMINISTRATION, CONTROLLED SUBSTANCES ACT, at
http://www.usdoj.gov/dea/agency/csa.htm (last visited May 13, 2004).
133. Friedman, supra note 33, at 150.
134. See generally UNITED STATES DRUG ENFORCEMENT ADMINISTRATION,
OXYCONTIN, at http://www.dea.gov/concern/oxycodone-factsheet.html (last visited
May 13, 2004).
135. See, e.g., http://www.oxycontin-oxycodone.com/brandname-oxycontin.htm
(last visited May 13,2004).
136. See generally FEDERAL BUREAU OF INVESTIGATION, FRAUD TARGET:
SENIOR CITIZENS, at http://www.fbi.gov/majcases/fraud/seniorsfam.htm (last visited
May 13, 2004).
137. Id.
138. FEDERAL BUREAU OF INVESTIGATION, FRAUD ON THE INTERNET, at
http://www.fbi.gov/majcases/fraud/internetschemes.htm (last visited May 13, 2004).
139. See Internet Fraud Complaint Center website, at http://www.ifccfbi.gov/
index.asp (last visited May 13, 2004).
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levels to quantify fraud patterns and provide statistical data on current
fraud trends. 14°
V. INVITING THE FEDERAL GOVERNMENT: THE NEED FOR UNIFORM
REGULATION
A. Do we need new legislation, or can agencies act under existing
statute?
1. The Non-delegation doctrine
The first issue that arises when making the case for uniform
regulation via federal agencies is whether Congress can delegate its
legislative powers to an agency. The Constitution states that "all
legislative powers . . . shall be vested in a Congress of the United
States. 141 Section 8 of Article 1 provides Congress with the power to
"make all laws which are necessary and proper for carrying into
execution ... vested by this Constitution in the Government of the
United States."'42  As Dean William Fox aptly points out,'43 the
Constitution appears to give exclusive power to Congress to legislate
while permitting Congress to authorize other governmental bodies to
legislate in its place. 44
The Supreme Court recognized early on in Wayman v. Southard1
45
that Congress could not be expected to run the daily operations of the
whole country. The Court accepted that Congress had the power to
delegate but limited Congress from giving broad delegations to
administrative agencies.' 6 The Court required Congress to establish
the general framework of the regulatory program while leaving to the
141
agencies the implementation decisions.
140. Id.
141. U.S. Const, art. I, § 1.
142. U.S. Const, art. I, § 8.
143. WILLIAM F. Fox, JR., UNDERSTANDING ADMINISTRATIVE LAw 32 (3rd ed.
1997).
144. Id.
145. Wayman v. Southard, 23 U.S. (10 Wheat.) 1 (1825).
146. Id. at 27.
147. Id. at 27.
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The Court did not use the non-delegation doctrine to invalidate
Congress' actions until 1935. That year the Supreme Court, on two
separate occasions, struck down Congress' grant of legislative power to
the Executive and invalidated two of Roosevelt's New Deal
programs. 48 The Court has not used the non-delegation doctrine to
invalidate Congress' delegation of power to agencies and other
governmental bodies since 1935.49
Federal agencies are created by statute.150 Each agency's scope of
authority is limited by Congress and is delineated in the agency's
enabling act.15' The Administrative Procedure Act (APA)'5 2 sets forth
the procedures that all agencies, unless Congress has provided for an
exception, must follow. 15 3 The enabling acts and the APA set forth the
minimum requirements for agencies that are then allowed to fill in the
gaps by exercising discretion.14 This discretion derives from Congress'
belief that agencies have the expertise in their particular area of
regulation and should be in charge of developing the detailed
regulation that is necessary to carry out Congress' will.
155
2. Preemption
The second issue that arises when calling for federal regulation of
Internet prescription sales is what happens should there be an
inconsistency between a new federal law and a state statute. In
Gibbons v. Ogden, 56 Justice Marshall stated that if there is a
"collision" between a valid constitutional Act of Congress and a state
statute, the state law "must yield to the law of Congress.
'
,
57
148. Panama Refining Co. v. Ryan, 293 U.S. 388 (1935); A.L.A. Schecter
Poultry Corp. v. U.S., 293 U.S. 495 (1935).
149. STEPHEN G. BREYER ET AL., ADMINISTRATIVE LAW AND REGULATORY
POLICY 44 (5" ed. 2002).
150. Fox, supra note 143, at 4-5.
151. Id. at 5.
152. 5 U.S.C. §§ 551-808 (2000).
153. Fox, supra note 143, 195-197.
154. Id. at 6.
155. Id.
156. Gibbons v. Ogden, 22 U.S. (9 Wheat.) 1 (1824).
157. Id. at 31.
2004]
562 Journal of Contemporary Health Law and Policy [Vol. 20:541
In Napier v. Atlantic Coast Line,""8 the Supreme Court took up the
conflict between the Interstate Commerce Commission's rules and
state law. The Court held that when Congress grants power to an
agency to prescribe rules, Congress "intends to occupy the field" and
state law must yield. 9
In Rice v. Santa Fe Elevator Corporation,'6 the Court took up the
issue over what happens when states have traditionally occupied the
field and Congress subsequently legislates. The Court began "with the
assumption that the historic police powers of the States were not to be
superseded by the Federal Act, unless that was the clear and manifest
purpose of Congress.' ' 61 The Court emphasized that the scheme of
federal regulation has to be "pervasive as to make reasonable the
inference that Congress left no room for the States to supplement it.'
62
The current lack of an adequate regulatory framework to ensure the
safety of prescriptions purchased online demonstrates the need for
Congress to act and give the appropriate federal agencies broad power
to fashion a solution for the current regulatory vacuum. If Congress
acts and occupies the field, state laws that conflict with federal law will
have to yield. This does not mean there is no role for the states, only
that the federal government will take on the primary responsibility for
regulating Internet prescription drug sales.
B. Making the Case for Federal Regulation
Each federal body now regulates a small portion of online drug sales.
The result is a lack of cohesiveness among the regulations. Proper
federal regulation can only be achieved if the federal government
devises a thorough legislative framework that outlines the policy goal.
This all-encompassing legislation should allow the agencies to work
closely together to share information on implementation of new laws
and to share power when regulating online pharmacies.
This would not require the creation of a new federal agency. The
federal government can actively and effectively regulate online
pharmacies by giving one agency, such as the FDA, primary authority
for regulating the sale of prescription drugs over the Internet. Even
158. Napier v. Atlantic Coast Line, 272 U.S. 605 (1926).
159. Id. at 611.
160. Rice v. Santa Fe Elevator Corp., 331 U.S. 218 (1947).
161. Id. at 230.
162. Id.
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though the FDA does not currently have explicit authority to regulate
Internet prescription drug sales, Congress has the power to amend and
broaden an agency's enabling act.
161
Congress can act under this authority to safeguard consumers
purchasing prescriptions over the Internet. The FDA should be given
the necessary authority and resources to monitor the sale of
prescription drugs online, regulate the importation of drugs from
abroad, set up labeling standards for drugs that come from overseas,
and ensure that all drugs that enter the country have been approved by
the FDA for domestic use. In addition, the FDA should continue to
have primary responsibility for enforcing all aspects of drug labeling.
64
Moreover, the DOJ could use its own sub-agencies, such as the DEA,
to continue to enforce the Controlled Substances Act. The FBI, for
example, could investigate violations of the law that do not involve
abuse of controlled substances.
Ideally, each agency's authority to promulgate rules would be clearly
marked; however, that is not always the case. For instance, the FTC's
current role in ensuring truthful labeling overlaps with the FDA's role
in ensuring that prescription labels are what they purport to be. Any
new legislative efforts from Congress should strive to delineate each
agency's power and to eliminate any duplicative efforts.
163. Recently, Congress amended the FTC's enabling act to allow it to
"implement and enforce a national do-not-call registry." H.R. 3161, 107th Cong.
(2003). Before, the FTC could not enforce a national do-not-call registry because
it exceeded the FTC's authority under its enabling act. Under the Telephone
Consumer Protection Act of 1991 (TCPA), 47 U.S.C. § 227 (c)(1)(A)-(E), (c)(3)
(2004), the Federal Communications Commission (FCC) was given the authority
to promulgate rules to protect consumers from receiving unwanted telemarketing
calls. The TCPA did not require the FCC to implement a national do-not-call
registry, and the FCC chose not to create the registry. Mainstream Marketing
Services, Inc. v. FTC, 284 F. Supp. 2d 1151 (2003). The Telemarketing Act of 1994,
15 U.S.C. § 6102 (2004), gives the FTC power to promulgate rules to curb "abusive
telemarketing practices." In Mainstream Marketing Services, however, Judge
Nottingham found the FTC's rules did not allow it to create a federal registry.
Mainstream Marketing Services, 284 F. Supp. 2d at 1151. The decision generated a
public outcry leading Congress to amend the FTC's enabling act the next day. H.R.
3161, 108th Cong. (2003).
164. 15 U.S.C. § 1451 (2003).
165. 21 U.S.C. § 801 (2004).
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C. Current Legislative Efforts
The urgency of addressing the current regulatory vacuum grows
exponentially as online drug sales continue to expand in the United
States' health care landscape.' 66 While lawmakers are aware of the
need to address the current legislative vacuum,67 various obstacles
have thus far prevented such action. Lack of agreement amongst
lawmakers on how to proceed,1'6 the powerful lobby of drug
companies, and a lack of consumer education are some of the more
notable examples. Despite such obstacles, Congress now appears
ready to legislate in this field. The Senate has identified Internet
prescription drug sales and Internet pharmacies as a critical
component of any meaningful reform of Medicare. 171 In fact, a portion
of the proposed Medicare legislation introduced in 2002 was devoted
solely to the issue of Internet pharmacies. The narrow victory of the
Medicare Prescription drug legislation in the House of Representatives
reflects a deep divide in Congress over the issue of how to address
prescription drug sales. 73  Hence, any bill regulating Internet
prescription drug sales will face an uphill battle before it can make its
way to the President's desk.
166. In 1999, Rep. Ron Klink (D-PA) voiced concern that "a Wild West world
is unfolding before us, where many consumers are accessing potentially dangerous
drugs with little or no practical guidance. Yet because it is e-commerce, there is a
mentality: It must be progress." Flaherty & Gaul, supra note 11, at Al.
167. Id.
168. Scott, supra note 43, at 412.
169. In 2002 the Pharmaceutical Research and Manufacturers of America
donated $143,000 to Democrats and over $3 million to Republicans. Other
pharmaceutical donors included Aventis ($542,000 to Republicans), DuPont
Pharmaceuticals ($5,000 to Democrats). See COMMON CAUSE, THE SOFT MONEY
LAUNDROMAT, at http://www.commoncause.org/laundromat/stat/topdonorsOl.htm
(last visited May 13, 2004).
170. Health Care Expansion and Quality Improvement Act of 2003, S. 10, 108th
Cong. (2003).
171. Id.
172. S. 10 § 503B.
173. Id. The House approved the measure with 221 yeas and 208 nays.
Internet Drug Sales
1. The Prescription Drug Affordability Act
The Prescription Drug Affordability Act (PDAA) 7 4 was introduced
in the House of Representatives in 2003.175 The PDAA would amend
the Federal Food, Drug and Cosmetic Act (FDCA) to require that
accurate information be posted on the website of an Internet pharmacy
selling online. 176 The goal of this proposed legislation would be to
reduce barriers of importation for FDA approved drugs. Anyone who
wants to import a drug would have to submit an application to the
FDA, which then would approve the drug importation unless the drug
is adulterated or not approved for use in the U.S.
The PDAA would forbid the federal government from regulating
any Internet sales of FDA approved drugs if the drug importation
were done by a state-licensed pharmacist. 77 The PDAA's sponsor
178
believes that the federal government should have a laissez-faire
approach to Internet prescription drug sales and that "letting the free
market work is the best means of lowering the cost of prescriptions
drugs."' This bill would prevent the HHS Secretary from taking any
action against Internet pharmacies if the sale is made in compliance
with the Act.'8
As of the time of this writing, the PDAA was still in the
Subcommittee of Health without any major activity."' While the bill
takes a step in the right direction by securing cheaper prescription
drugs through lawful importation, the bill falls short of the needed
regulatory reform necessary to address consumer safety. In fact, it
limits the role of federal agencies in protecting consumers,
perpetuating the current problems associated with imposing on states
the burden to regulate online pharmacies.
174. See Prescription Drug Affordability Act, H.R. 616, 108th Cong. (2003).
175. Id. (introduced in the House of Rep. on Feb. 5, 2003).
176. H.R. 616 § 202.
177. Id.
178. Rep. Ron Paul, R-TX (107th Cong., 2003).
179. 149 CONG. REc. E190 (daily ed. Feb. 12, 2003) (statement of Rep. Ron
Paul), available at http://thomas.loc.gov/cgibin/query/D?r108:1:./temp/rlO82OY
C37:: (last visited May 13, 2004).
180. H.R. 616 § 202.
181. Id. H.R. 616 was introduced on Feb. 5, 2003, and on Feb. 12, 2003, it was
referred to the Subcommittee on Health. At the time of publication, there has
been no further action on this bill.
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2. Additional Legislative Proposals
Recently, two other legislative proposals dealing with online sales of
prescription drugs were introduced. The first one, the Internet
Pharmacy Consumer Protection Act,l 82 amends the FDCA by
prohibiting a person from dispensing a prescription drug if the
purchaser submitted the purchase order from an Internet site that does
not provide the following required information: name, address of the
principal place of business, and telephone number of the dispenser;
disclosure of each state in which the person is authorized by law to
dispense prescription drugs; and name of each individual who serves as
a pharmacist for the site and each state that she is authorized to
dispense prescription drugs. 83 In addition, if the site provides medical
consultation, then additional requirements must be met, such as
disclosure of the name of each individual who provides such
consultations and each state in which she is licensed or authorized by
law to provide such services.'9 The proposed legislation would
prohibit Internet prescription sales without an "appropriate medical
relationship. '"1 85 The Act requires at least one in-person medical
evaluation by a practitioner and a valid prescription.' 6
The Act would explicitly allow states to bring civil action in a United
States District Court on behalf of its residents for violations.""
Remedies available to the states include injunctive relief, damages,
restitution, and attorney's fees.18 The Act also provides for a two-year,
$100,000 per year grant to the FSMB for the purposes of (1)
identifying Internet sites that are in violation of state or federal laws;
(2) investigating violations; and (3) submitting evidence to the state
pharmacy licensing boards, the Attorney General, and the HHS
Secretary for further investigation.l9
182. Internet Pharmacy Consumer Protection Act, H.R. 3880, 108th Cong.
(2004).
183. H.R. 3880 § 2 (a).
184. Id.
185. Id. § 2(b).
186. Id.
187. Id. § 2(c).
188. Id.
189. Id. § 3(c).
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As of this writing, the Internet Pharmacy Consumer Protection
Act' 90 is in the Subcommittee on Health. It is still too early for any
further action to be contemplated. If passed, this bill would strike the
correct balance between the federal government and state
governments because it gives the FDA power to regulate, and the
Attorney General and the states power to prosecute. It protects
consumers by requiring substantial disclosure from online pharmacies,
and it ensures physicians rendering medical advice are licensed and
have a medical relationship with the patient by having a minimum of
- • 191
one in-person consultation. The Act looks to the federal government
to secure broad consumer protection and gives federal agencies the
power to enforce it while at the same time preserving an enforcement
role for states; the agency can obtain injunctive relief and effectively
shut down the fraudulent online pharmacy without needing each state
to bring an action. 92 This measure allows states to work together with
each other and with the federal government to strike the correct
balance that will afford consumers the greatest protection without
eliminating the states' traditional role in pharmacy licensing and
regulation.
3. Prescription Drug Abuse Elimination Act of 2004
The second most recent legislative proposal is the Prescription Drug
Abuse Elimination Act of 2004.93 The Act provides states with grants
for establishing a controlled substance prescription drug monitoring
program database. This database contains the name and address of the
user, the quantity dispensed, the number of refills ordered, the
estimated number of days for which such quantity should last, whether
it was a first-time request or a refill, date of dispensing, and the date ofthe oigina • •194
the original prescription. States are required to make the database
available to law enforcement and bona fide treating physicians.9
This measure aims at controlling prescription drug abuse on the
Internet. While the goal of the legislation is commendable, it raises
privacy questions and places a heavy administrative burden on States
190. H.R. 3880 was introduced on March 3,2004.
191. H.R. 3880 §503B (b)(2)(A).
192. Id. §503B (c)(1).
193. Prescription Drug Abuse Elimination Act of 2004, H.R. 3870, 108' Cong.
(2004).
194. Id.
195. Id.
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to gather and maintain a database with such detailed information. This
legislation helps prevent drug abuse by those who seek to use the
Internet for such purposes. However, it does not address the need for
protection for the innocent consumers who seek to legally purchase
safe medications online.
D. Outlining a Workable and Beneficial Federal Regulatory Role
Circumstances under which a doctor may appropriately prescribe
medications online196 should be limited to those instances in which
traditional doctors appropriately prescribe drugs relying solely on the
patient's medical history, without the need for a face-to-face
consultation. To safeguard this process, "online doctors" should be
required to obtain a copy of the medical records on file with the
patient's traditional doctor in order to determine potential adverse
reactions and examine the patient's medical history. The traditional
doctor may also have a role to play as a middleman. The patient
would shop for drug prices online, and the doctor's office would then
contact the online pharmacy to provide the prescription. Or, taking
that one step further, states could set up an online exchange system
where pharmacies compete on prices the same way as the online home
mortgage database system (i.e., Lendingtree.com). The system could
be used by patients who would use their regular prescriptions written
at the doctor's office.
Medicine in the twenty-first century provides physicians with an
array of choices for treating a malady. Decisions regarding which
drugs to order, potential fatal drug interactions, and whether the drugs
meet FDA's safety standards simply cannot be made by the consumer
in a regulatory vacuum. The consumer lacks both knowledge and the
necessary information to make those decisions and will be exploited in
the absence of a coherent regulatory regime.
Legalizing online pharmacies through a uniform regulatory
framework like that above also opens them to greater monitoring and
scrutiny by the managed care corporations. Eliminating the
"secrecy" in which many online pharmacies operate will help
distinguish those that are legitimate from those that are fraudulent.
Without such a uniform federal approach, given the discrepancies in
state laws and lack of coordination among numerous federal agencies
196. Scott, supra note 43, at 412.
197. Haney, supra note 62, at 581-582.
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in the area of online prescriptions, some consumers will go virtually
unprotected. The federal government has the "legal machinery" in
place to develop uniform regulation and to enforce and prosecute
violations through administrative agencies. State governments have a
role to play, not only in assisting the federal government with
enforcement matters, but also in regulating those areas left
unregulated by the federal government. Through the states' individual
boards of pharmacy, states can set standards for pharmacists and
physicians and issue licenses. They can also impose additional
penalties and prevent pharmacies from doing business within the state.
The case for uniform federal regulation is founded on the notion
that a consumer's life should not be placed in jeopardy merely because
his state has yet to begin the process of examining the risks associated
with online prescribing and dispensing of medication. Even if state
governments pass legislation in an attempt to regulate the field, a state
acting in its individual capacity simply does not have the power or the
financial resources to prosecute pharmacies located in other states or,
more importantly, overseas.
In the circumstance of foreign pharmacies, there is an even stronger
case for uniform federal regulation. Under the Constitution, states
cannot levy import duties'98 in order to discourage drug importation
due to safety issues. The executive branch is the only branch of
government that can appoint Ambassadors and enter into treaties with
other nations' 9 The channels of diplomacy can be used in an attempt
to rein in illegal foreign pharmacies. States simply do not have the
power to carry out diplomatic efforts on behalf of the United States.
Likewise, states do not have the power to impose unilateral sanctions
or trade embargos to compel nations where rogue pharmacies operate
to comply with U.S. laws.
If allowed to operate freely and with proper regulation, online
pharmacies will become powerful competitors in the pharmacy field.
Their lower prices will provide a powerful incentive for traditional
brick and mortar pharmacies to lower their own prices in order to
remain competitive. Traditional pharmacies can then pressure drug
manufacturers to decrease their robust profits and provide the
American consumer with drugs that are equivalent in price to its
Canadian and Mexican counterparts.
198. U.S. Const. art. I, § 10 c. 2.
199. U.S. Const, art. II, § 2 c. 2.
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VII. CONCLUSION
Maintaining the status quo is simply untenable. The current drug
regulation regime has grown obsolete in light of the burgeoning online
prescription drug industry, and does not reflect the reality of e-
commerce. The current patchwork of federal regulation puts
consumer safety at risk. Congress must act with the people's interest
in mind and provide for uniform federal regulation of Internet
prescription drug sales.
